eTheRNA Immunotherapies

eTheRNA Immunotherapies' mission is to help patients overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system. eTheRNA's proprietary mRNA-based TriMix technology enhances dendritic cells, thereby boosting the patient's immune system more comprehensively, sustainably, and safely than any other similar approach studied to date.